In addition, this study demonstrates, in accordance with our murine data, that some patients with pancreatic cancer exhibit raised IL-6 levels when they are pre-cachectic, and that they may exhibit the triad of raised IL-6 levels, reduced ketone levels, and raised glucocorticoid levels when they are cachectic. The gene discussed is IL6; the disease is familial pancreatic carcinoma.